サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1695017

低分子CMO/CDMOの世界市場レポート 2025年

Small Molecule CMO/CDMO Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
低分子CMO/CDMOの世界市場レポート 2025年
出版日: 2025年03月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

低分子CMO/CDMO市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.7%で、733億米ドルに成長します。予測期間の成長は、医薬品パイプラインの増加、製薬業務の世界化、柔軟な製造への需要、規制遵守の専門知識、バイオ医薬品の融合に起因しています。予測期間における主な動向としては、持続可能で環境に優しい製造方法、コラボレーションとパートナーシップの増加、個別化医療とニッチ治療、仮想および仮想現実企業の増加、デジタル技術の統合、迅速な対応製造などが挙げられます。

医薬品需要の増加は、今後の低分子CMO/CDMO市場の成長を牽引すると予想されます。製薬業界は、政府部門と民間部門の両方による医薬品や医薬品の発見、開発、生産を包含しています。低分子CMO/CDMOサービスは、製薬業界において低分子医薬品の開発、製造、包装などの様々な機能をアウトソーシングするために利用されています。このアウトソーシングにより、製薬企業はコスト削減、時間短縮、プロセスの合理化を図ることができます。例えば、2024年8月、国の政府機関であるカナダ政府は、医薬品分野の国内輸出が2022年には95億9,000万米ドル（127億9,000万カナダドル）に達し、2021年の107億1,000万カナダドルから増加したと報告しました。また、輸入は2021年の266億3,000万カナダドルから302億1,000万カナダドルに増加しました。このように、医薬品需要の拡大が低分子CMO/CDMO市場の拡大を促す重要な要因となっています。

低分子CMO/CDMO市場の主要企業は、上海の最先端低分子プラットフォームなど、CDMOサービスを強化する革新的技術に注力しています。このプラットフォームは、低分子医薬品をより効率的に開発・生産することを目的とした最先端の技術革新を象徴しています。2023年6月、中国の製薬会社であるPorton Pharma Solutions Ltd.は、上海で最先端の低分子プラットフォームを立ち上げました。このプラットフォームは、低分子医薬品のライフサイクル全体を前進させるために、先進的な技術と方法論を組み合わせることで全体的なアプローチを採用しています。このプラットフォームは、ワンストップショップのソリューション、柔軟性、可用性、デジタルトランスフォーメーションを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の低分子CMO/CDMO PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の低分子CMO/CDMO市場：成長率分析
  • 世界の低分子CMO/CDMO市場の実績：規模と成長、2019年～2024年
  • 世界の低分子CMO/CDMO市場の予測：規模と成長、2024年～2029年、2034年
  • 世界の低分子CMO/CDMO総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の低分子CMO/CDMO市場：製品別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 低分子医薬品
  • 低分子API
  • 世界の低分子CMO/CDMO市場：ステージタイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 臨床
  • 商業用
  • 前臨床
  • 世界の低分子CMO/CDMO市場：治療領域別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 腫瘍学
  • 神経学
  • 感染症
  • 心血管疾患
  • 呼吸器疾患
  • 代謝障害
  • その他の治療法
  • 世界の低分子CMO/CDMO市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 心臓血管
  • 腫瘍学
  • 糖尿病
  • 免疫疾患
  • 世界の低分子CMO/CDMO市場、低分子医薬品のサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 固形剤形（錠剤、カプセル剤）
  • 液体剤形（注射剤、溶液剤）
  • 局所投与剤形
  • 世界の低分子CMO/CDMO市場、小分子API（医薬品有効成分）のサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 汎用API
  • ブランドAPI
  • カスタム合成API

第7章 地域別・国別分析

  • 世界の低分子CMO/CDMO市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 世界の低分子CMO/CDMO市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 低分子CMO/CDMO市場：競合情勢
  • 低分子CMO/CDMO市場：企業プロファイル
    • Patheon NV（Thermo Fisher Scientific）Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline Overview, Products and Services, Strategy and Financial Analysis
    • Johnson Matthey plc Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • WuXi AppTec Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Catalent Inc.
  • Aurobindo Pharma
  • Fareva
  • Aesica Pharmaceuticals Limited
  • Siegfried holdings AG
  • Recipharm AB
  • Jubilant Life Sciences Limited
  • Almac Group
  • Piramal Pharma Solutions
  • Oxford Chemicals Inc.
  • Syngene International Limited
  • Novasep
  • Pfizer CentreOne
  • GVK Biosciences
  • ChemPartner

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 低分子CMO/CDMO市場2029年：新たな機会を提供する国
  • 低分子CMO/CDMO市場2029年：新たな機会を提供するセグメント
  • 低分子CMO/CDMO市場2029年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r28995

A small-molecule Contract Manufacturing Organization (CMO) or Contract Development and Manufacturing Organization (CDMO) is a business entity that offers services to pharmaceutical companies on a contractual basis. These services encompass various aspects of the pharmaceutical development lifecycle, including contract development, manufacturing, and packaging of small-molecule drugs. Small-molecule CMOs/CDMOs play a crucial role in assisting other companies in the pharmaceutical industry to complete projects and navigate through the regulatory submission process.

Small-molecule Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) are primarily classified into two categories, small-molecule drug products and small-molecule Active Pharmaceutical Ingredient (API). The term "small-molecule drug product" denotes the final form of a medicinal product that incorporates an active pharmaceutical ingredient composed of small molecules. This involves comprehensive stages, including clinical, commercial, and preclinical development. These drug products find applications in therapeutic areas such as oncology, neurology, infectious diseases, cardiovascular diseases, respiratory disorders, metabolic disorders, among others. The end-users of these services are entities specializing in cardiovascular, oncology, diabetes, and immunological disorders.

The small-molecule CMO/CDMO market research report is one of a series of new reports from The Business Research Company that provides small-molecule CMO/CDMO market statistics, including small-molecule CMO/CDMO industry global market size, regional shares, competitors with a small-molecule CMO/CDMO market share, detailed small-molecule CMO/CDMO market segments, market trends and opportunities, and any further data you may need to thrive in the small-molecule CMO/CDMO industry. This small-molecule CMO/CDMO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small molecule CMO/CDMO market size has grown strongly in recent years. It will grow from $50.58 billion in 2024 to $54.58 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to favorable government support, cost-effective solutions, growing complexity in drug development, industry consolidation, focus on core competencies.

The small molecule CMO/CDMO market size is expected to see strong growth in the next few years. It will grow to $73.3 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rise in drug pipelines, globalization of pharmaceutical operations, demand for flexible manufacturing, regulatory compliance expertise, biopharmaceutical convergence. Major trends in the forecast period include sustainable and green manufacturing practices, increased collaboration and partnerships, personalized medicine and niche therapies, rise in virtual and virtual-to-reality companies, integration of digital technologies, rapid response manufacturing.

The increasing demand for pharmaceuticals is anticipated to drive the growth of the small-molecule CMO/CDMO market in the future. The pharmaceutical industry encompasses the discovery, development, and production of drugs and medicines by both government and private sectors. Small-molecule CMO/CDMO services are utilized in the pharmaceutical industry to outsource various functions, such as the development, manufacturing, and packaging of small-molecule drugs. This outsourcing enables pharmaceutical companies to reduce costs, save time, and streamline their processes. For example, in August 2024, the Government of Canada, a national government agency, reported that domestic exports in the pharmaceutical sector rose to $9.59 billion USD (12.79 billion CAD) in 2022, an increase from 10.71 billion CAD in 2021. Additionally, imports rose to 30.21 billion CAD, up from 26.63 billion CAD in 2021. Thus, the growing demand for pharmaceuticals is a key factor driving the expansion of the small-molecule CMO/CDMO market.

Major companies in the small-molecule CMO/CDMO market are focusing on innovative technologies to enhance CDMO services, such as the state-of-the-art small-molecule platform in Shanghai. This platform represents cutting-edge technological innovations aimed at developing and producing small-molecule drugs more efficiently. In June 2023, Porton Pharma Solutions Ltd., a China-based pharmaceutical company, launched a state-of-the-art small-molecule platform in Shanghai. This platform adopts a holistic approach by combining advanced technologies and methodologies to advance the entire lifecycle of small-molecule pharmaceuticals. It offers one-stop-shop solutions, flexibility, availability, and digital transformation.

In March 2023, Catalent Inc., a US-based pharmaceutical company, entered into a partnership with Grunentha GmbH, a Germany-based pharmaceutical company. This partnership is focused on expediting clinical development timelines for an orally dosed small molecule in Grunenthal's pipeline. The collaboration aims to improve the bioavailability of the small molecule and reduce the Phase 1 development timeline. Grunenthal GmbH is actively engaged in partnerships and agreements with contract development and manufacturing organizations (CDMOs).

Major companies operating in the small molecule CMO/CDMO market report are Patheon NV (Thermo Fisher Scientific), GlaxoSmithKline, Johnson Matthey PLC, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Avid Bioservices Inc., Dishman Carbogen Amcis Ltd., ProChem Inc., Metrics Contract Services

North America was the largest region in the Small Molecule CMO/CDMO market in 2024. The regions covered in the Small Molecule CMO/CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Small Molecule CMO/CDMO market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small-molecule contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as drug development services, process scale-up, quality control and testing, technology transfer, and clinical trial support. The market value includes the value of related goods sold by the service provider or included within the service offering. The small-molecule contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO) market also includes sales of active pharmaceutical ingredients, drug intermediates, and drug formulation. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Molecule CMO/CDMO Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule cmo/cdmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule cmo/cdmo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small molecule cmo/cdmo market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Small Molecule Drug Product; Small Molecule API
  • 2) By Stage Type: Clinical; Commercial; Preclinical
  • 3) By Therapeutic Area: Oncology; Neurology; Infectious Disease; Cardiovascular Disease; Respiratory Disorders; Metabolic Disorders; Other Therapeutics
  • 4) By Application: Cardiovascular; Oncology; Diabetes; Immunological Disorders
  • Subsegments:
  • 1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules); Liquid Dosage Forms (Injectables, Solutions); Topical Dosage Forms
  • 2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs; Branded APIs; Custom Synthesis APIs
  • Companies Mentioned: Patheon NV (Thermo Fisher Scientific); GlaxoSmithKline; Johnson Matthey plc; Lonza Group Ltd.; WuXi AppTec
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Molecule CMO/CDMO Market Characteristics

3. Small Molecule CMO/CDMO Market Trends And Strategies

4. Small Molecule CMO/CDMO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Small Molecule CMO/CDMO Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Small Molecule CMO/CDMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Small Molecule CMO/CDMO Market Growth Rate Analysis
  • 5.4. Global Small Molecule CMO/CDMO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Small Molecule CMO/CDMO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Small Molecule CMO/CDMO Total Addressable Market (TAM)

6. Small Molecule CMO/CDMO Market Segmentation

  • 6.1. Global Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Molecule Drug Product
  • Small Molecule API
  • 6.2. Global Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical
  • Commercial
  • Preclinical
  • 6.3. Global Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Neurology
  • Infectious Disease
  • Cardiovascular Disease
  • Respiratory Disorders
  • Metabolic Disorders
  • Other Therapeutics
  • 6.4. Global Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular
  • Oncology
  • Diabetes
  • Immunological Disorders
  • 6.5. Global Small Molecule CMO/CDMO Market, Sub-Segmentation Of Small Molecule Drug Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Dosage Forms (Tablets, Capsules)
  • Liquid Dosage Forms (Injectables, Solutions)
  • Topical Dosage Forms
  • 6.6. Global Small Molecule CMO/CDMO Market, Sub-Segmentation Of Small Molecule API (Active Pharmaceutical Ingredient), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Generic APIs
  • Branded APIs
  • Custom Synthesis APIs

7. Small Molecule CMO/CDMO Market Regional And Country Analysis

  • 7.1. Global Small Molecule CMO/CDMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Small Molecule CMO/CDMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Molecule CMO/CDMO Market

  • 8.1. Asia-Pacific Small Molecule CMO/CDMO Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Molecule CMO/CDMO Market

  • 9.1. China Small Molecule CMO/CDMO Market Overview
  • 9.2. China Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Molecule CMO/CDMO Market

  • 10.1. India Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Molecule CMO/CDMO Market

  • 11.1. Japan Small Molecule CMO/CDMO Market Overview
  • 11.2. Japan Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Molecule CMO/CDMO Market

  • 12.1. Australia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Molecule CMO/CDMO Market

  • 13.1. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Molecule CMO/CDMO Market

  • 14.1. South Korea Small Molecule CMO/CDMO Market Overview
  • 14.2. South Korea Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Molecule CMO/CDMO Market

  • 15.1. Western Europe Small Molecule CMO/CDMO Market Overview
  • 15.2. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Molecule CMO/CDMO Market

  • 16.1. UK Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Molecule CMO/CDMO Market

  • 17.1. Germany Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Molecule CMO/CDMO Market

  • 18.1. France Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Molecule CMO/CDMO Market

  • 19.1. Italy Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Molecule CMO/CDMO Market

  • 20.1. Spain Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Molecule CMO/CDMO Market

  • 21.1. Eastern Europe Small Molecule CMO/CDMO Market Overview
  • 21.2. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Molecule CMO/CDMO Market

  • 22.1. Russia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Molecule CMO/CDMO Market

  • 23.1. North America Small Molecule CMO/CDMO Market Overview
  • 23.2. North America Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Molecule CMO/CDMO Market

  • 24.1. USA Small Molecule CMO/CDMO Market Overview
  • 24.2. USA Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Molecule CMO/CDMO Market

  • 25.1. Canada Small Molecule CMO/CDMO Market Overview
  • 25.2. Canada Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Molecule CMO/CDMO Market

  • 26.1. South America Small Molecule CMO/CDMO Market Overview
  • 26.2. South America Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Molecule CMO/CDMO Market

  • 27.1. Brazil Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Molecule CMO/CDMO Market

  • 28.1. Middle East Small Molecule CMO/CDMO Market Overview
  • 28.2. Middle East Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Molecule CMO/CDMO Market

  • 29.1. Africa Small Molecule CMO/CDMO Market Overview
  • 29.2. Africa Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Molecule CMO/CDMO Market Competitive Landscape And Company Profiles

  • 30.1. Small Molecule CMO/CDMO Market Competitive Landscape
  • 30.2. Small Molecule CMO/CDMO Market Company Profiles
    • 30.2.1. Patheon NV (Thermo Fisher Scientific) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. GlaxoSmithKline Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Johnson Matthey plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. WuXi AppTec Overview, Products and Services, Strategy and Financial Analysis

31. Small Molecule CMO/CDMO Market Other Major And Innovative Companies

  • 31.1. Catalent Inc.
  • 31.2. Aurobindo Pharma
  • 31.3. Fareva
  • 31.4. Aesica Pharmaceuticals Limited
  • 31.5. Siegfried holdings AG
  • 31.6. Recipharm AB
  • 31.7. Jubilant Life Sciences Limited
  • 31.8. Almac Group
  • 31.9. Piramal Pharma Solutions
  • 31.10. Oxford Chemicals Inc.
  • 31.11. Syngene International Limited
  • 31.12. Novasep
  • 31.13. Pfizer CentreOne
  • 31.14. GVK Biosciences
  • 31.15. ChemPartner

32. Global Small Molecule CMO/CDMO Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Molecule CMO/CDMO Market

34. Recent Developments In The Small Molecule CMO/CDMO Market

35. Small Molecule CMO/CDMO Market High Potential Countries, Segments and Strategies

  • 35.1 Small Molecule CMO/CDMO Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Small Molecule CMO/CDMO Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Small Molecule CMO/CDMO Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer